Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 142

1.

HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.

Merindol N, El-Far M, Sylla M, Masroori N, Dufour C, Li JX, Cherry P, Plourde MB, Tremblay C, Berthoux L.

PLoS Pathog. 2018 Nov 12;14(11):e1007398. doi: 10.1371/journal.ppat.1007398. eCollection 2018 Nov.

2.

CD16+ monocytes give rise to CD103+RALDH2+TCF4+ dendritic cells with unique transcriptional and immunological features.

Wacleche VS, Cattin A, Goulet JP, Gauchat D, Gosselin A, Cleret-Buhot A, Zhang Y, Tremblay CL, Routy JP, Ancuta P.

Blood Adv. 2018 Nov 13;2(21):2862-2878. doi: 10.1182/bloodadvances.2018020123.

3.

Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial.

Roux P, Fressard L, Suzan-Monti M, Chas J, Sagaon-Teyssier L, Capitant C, Meyer L, Tremblay C, Rojas-Castro D, Pialoux G, Molina JM, Spire B.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e69-e75. doi: 10.1097/QAI.0000000000001781.

PMID:
30212434
4.

Anti-Gag antibodies gag HIV infection and slow disease progression.

Ahmad A, Mehraj V, Jenabian MA, Routy JP, Tremblay C.

AIDS. 2018 Jun 19;32(10):1373-1375. doi: 10.1097/QAD.0000000000001852. No abstract available.

PMID:
29851665
5.

Deciphering natural control of HIV-1: A valuable strategy to achieve antiretroviral therapy termination.

Loucif H, Gouard S, Dagenais-Lussier X, Murira A, Stäger S, Tremblay C, Van Grevenynghe J.

Cytokine Growth Factor Rev. 2018 Apr;40:90-98. doi: 10.1016/j.cytogfr.2018.03.010. Epub 2018 Apr 5. Review.

PMID:
29778137
6.

Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study.

Diabaté S, Chamberland A, Geraldo N, Tremblay C, Alary M.

PLoS One. 2018 May 10;13(5):e0197251. doi: 10.1371/journal.pone.0197251. eCollection 2018.

7.

HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation.

Allam O, Samarani S, Mehraj V, Jenabian MA, Tremblay C, Routy JP, Amre D, Ahmad A.

PLoS One. 2018 Mar 30;13(3):e0194185. doi: 10.1371/journal.pone.0194185. eCollection 2018.

8.

The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.

Wacleche VS, Tremblay CL, Routy JP, Ancuta P.

Viruses. 2018 Feb 6;10(2). pii: E65. doi: 10.3390/v10020065. Review.

9.

Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.

Mehraj V, Cox J, Lebouché B, Costiniuk C, Cao W, Li T, Ponte R, Thomas R, Szabo J, Baril JG, Trottier B, Côté P, LeBlanc R, Bruneau J, Tremblay C, Routy JP; Montreal Primary HIV-Infection Study Group.

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25034.

10.

HIV-1 envelope sequence-based diversity measures for identifying recent infections.

Kafando A, Fournier E, Serhir B, Martineau C, Doualla-Bell F, Sangaré MN, Sylla M, Chamberland A, El-Far M, Charest H, Tremblay CL.

PLoS One. 2017 Dec 28;12(12):e0189999. doi: 10.1371/journal.pone.0189999. eCollection 2017.

11.

Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.

Durand-Zaleski I, Mutuon P, Charreau I, Tremblay C, Rojas D, Pialoux G, Chidiac C, Capitant C, Spire B, Cotte L, Chas J, Meyer L, Molina JM; ANRS IPERGAY Study Group.

AIDS. 2018 Jan 2;32(1):95-102. doi: 10.1097/QAD.0000000000001658.

PMID:
29210777
12.

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network.

CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494. No abstract available. Erratum in: CMAJ. 2018 Jun 25;190(25):E782.

13.

Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada.

Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, de Pokomandy A, Loutfy MR, Anema A, Becker D, Brotto L, Carter A, Cardinal C, Colley G, Ding E, Duddy J, Gataric N, Hogg RS, Hosward T, Jabbari S, Jones E, Kestler M, Langlois A, Lima V, Lloyd-Smith E, Medjuck M, Miller C, Money D, Nicholson V, Ogilvie G, Patterson S, Pick N, Roth E, Salters K, Sanchez M, Sas J, Sereda P, Summers M, Tom C, Wang L, Webster K, Zhang W, Abdul-Noor R, Angel J, Barry F, Bauer G, Beaver K, Benoit A, Bertozzi B, Borton S, Bourque T, Brophy J, Burchell A, Carlson A, Cioppa L, Cohen J, Conway T, Cooper C, Cotnam J, Cousineau J, Fraleigh A, Gagnier B, Gasingirwa C, Greene S, Hart T, Islam S, Kaushic C, Kennedy L, Kerr D, Kiboyogo M, Kwaramba G, Leonard L, Lewis J, Logie C, Margolese S, Muchenje M, Ndungʼu M, OʼBrien K, Ouellette C, Powis J, Quan C, Raboud J, Rachlis A, Ralph E, Rourke S, Rueda S, Sandre R, Smaill F, Smith S, Tigere T, Tharao W, Walmsley S, Wobeser W, Yee J, Yudin M, Baril JG, Burke NB, Clément P, Dayle J, Dubuc D, Fernet M, Groleau D, Hot A, Klein M, Martin C, Massie L, Ménard B, OʼBrien N, Otis J, Peltier D, Pierre A, Proulx-Boucher K, Rouleau D, Savoie É, Tremblay C, Trottier B, Trottier S, Tsoukas C, Gahagan J, Hankins C, Masching R, Ogunnaike-Cooke S.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):144-153. doi: 10.1097/QAI.0000000000001589.

14.

Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.

El-Far M, Tremblay CL.

Curr Opin HIV AIDS. 2018 Jan;13(1):38-44. doi: 10.1097/COH.0000000000000426. Review.

15.

HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.

Jackson E, Zhang CX, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, Gilbert L, Bruneau J, Thomas R, Côté P, Trottier B, LeBlanc R, Rouleau D, Tremblay C, Tsoukas CM, Routy JP, Ni X, Mabanga T, Bernard NF; Montreal Primary Infection Study Group.

PLoS One. 2017 Sep 22;12(9):e0185160. doi: 10.1371/journal.pone.0185160. eCollection 2017.

16.

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL; investigators of the Canadian HIV and Aging Cohort Study.

BMC Infect Dis. 2017 Sep 11;17(1):611. doi: 10.1186/s12879-017-2692-2.

17.

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L; ANRS IPERGAY Study Group.

Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.

PMID:
28747274
18.

Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.

Delaugerre C, Antoni G, Mahjoub N, Pialoux G, Cua E, Pasquet A, Hall N, Tremblay C, Cotte L, Capitant C, Chaix ML, Meyer L, Molina JM; IPERGAY Study Group.

J Infect Dis. 2017 Aug 1;216(3):382-386. doi: 10.1093/infdis/jix297.

PMID:
28666370
19.

Differential synthesis and release of IL-18 and IL-18 Binding Protein from human platelets and their implications for HIV infection.

Allam O, Samarani S, Jenabian MA, Routy JP, Tremblay C, Amre D, Ahmad A.

Cytokine. 2017 Feb;90:144-154. doi: 10.1016/j.cyto.2016.10.016. Epub 2016 Dec 1.

PMID:
27914933
20.

A potentially protective role of IL-18 Binding Protein in HIV-infected Long-Term Non-Progressors.

Iannello A, Samarani S, Allam O, Jenabian MA, Mehraj V, Amre D, Routy JP, Tremblay C, Ahmad A.

Cytokine. 2017 Feb;90:96-99. doi: 10.1016/j.cyto.2016.10.018. Epub 2016 Nov 16.

PMID:
27863336

Supplemental Content

Loading ...
Support Center